Could a pre-treatment boost t-cell power against myeloma?
Disease control
Recruiting now
This early-phase study tests whether giving sirolimus before standard bispecific antibody therapy can improve T-cell function and treatment response in people with multiple myeloma. About 10 participants will receive sirolimus first, then the antibody treatment. The main goals ar…
Phase: PHASE1 • Sponsor: Christopher Strouse • Aim: Disease control
Last updated Jun 27, 2026 13:03 UTC